
Overview
Curtis Health Caps is a leader in contract manufacturing of pharmaceutical products, specializing in soft capsules and liquid forms. The company produces medicinal products, dietary supplements, cosmetics, and animal feed additives, offering comprehensive support from conceptual processes to packaging and logistics. They manufacture over 1.4 billion soft capsules and 8 million liquid packages annually, providing a wide range of formulations and product ideas for various target groups.
Financials
Revenue history (in m)
From the notes
| Profit allocation | Retained in reserve capital | |
| Loans and borrowings | $3,030,245 | |
| Capital expenditure | $633,340 | |
| Planned capital expenditure (next year) | $2,068,412 | |
| Revenue structure | sprzedaż produktów | |
| Receivables write-downs | $336,874 |
Filing timeliness
Financial statements were filed on time, on average 82 days early. All were audited by a statutory auditor.
- 2025filed
- 202415/07/2025
- 202310/05/2024
- 202219/04/2023
- 202102/05/2022
- 202016/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medicine production
- Soft capsules
- Liquid forms
- Medical devices
- Dietary supplements
- Cosmetics
- Analytical research
- Stability testing
Websites
The site is available in: Polish and English.
- curtishealthcaps.comProdukcja kontraktowa produktów farmaceutycznych | CHC Curtis Health CapsWordPress 3.7Yoast SEOPPolylangApache
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2021.
| Mark | Protected until | |
|---|---|---|
| CHC CHCemy | – |
Job offers
The company has its own careers page: curtishealthcaps.com/kariera.
Authorized Representatives
Manner of representation
To make declarations of will on behalf of the company, joint action of two members of the management board is required. If there is a one-person management board, the sole member of the management board is authorised to make declarations of will on behalf of the company.
Supervisory board
Ownership
| Owner | Share value | Stake |
|---|---|---|
Mountplace Trading & Investments Limited | $9,751,485.68 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
08 1050 1520 1000 0090 3257 6275
30 1050 1520 1000 0090 3257 6267
69 1020 4027 0000 1102 1651 9597
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $1.7M$1,693,303 |
Buildings and premises | $12.5M$12,461,967 |
Properties named as collateral
Nieruchomości spółki położone w Wysogotowie |
Secured liabilities
| Type | Secures | |
|---|---|---|
Joint contractual mortgage | Overdraft facility and investment loans in PLN and EUR | |
Assignment of monetary claims under property insurance agreements | Overdraft facility and investment loans in PLN and EUR with PKO BP; investment loan with ING | |
Patronage declaration | Overdraft facility |
Public aid
11 public aid cases recorded, with a total value of $437,154.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 31, 2025 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $4,496$4,496 | Wójt Gminy Tarnowo Podgórne | |
| Jan 31, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,900$3,900 | Wójt Gminy Tarnowo Podgórne | |
| Jul 20, 2023 | Liquidity support for undertakings affected by the war in Ukraine | $119.2K$119,158 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prosuplement Group sp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Efferta Pharma sp. z o.o. | $33,051,786.19 | efferta.pl | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Global Pharma Cm S.A. | $24,132,016.98 | globalpharma.pl | ||
| Master Pharm S.A. | $23,116,954.19 | masterpharm.pl | ||
| Symbiofarm Krok sp. k. | $16,922,181.13 | symbiofarm.pl | ||
| Europharma Alliance sp. z o.o. | $15,439,864.68 | pharmaalliance.eu | ||
| Valentis Polska sp. z o.o. | $13,271,939.35 | valentis.pl | ||
| Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o. | $10,474,927.81 | ichem.com.pl |
FAQ
Last updated: 2026-04-10